Enjoy complimentary customisation on priority with our Enterprise License!
About Intranasal Drug Delivery
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.
TechNavio's analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:
TechNavio's report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
Key Vendors
Other Prominent Vendors
Market Driver
Market Challenge
Market Trend
Key Questions Answered in this Report
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.1.1 Market Size and Forecast
06.2 Five Forces Analysis
07. Market Segmentation by Product
07.1 Global Intranasal Drug Delivery market by Product 2013-2018
08. Geographical Segmentation
08.1 Global Intranasal Drug Delivery Market by Geographical Segmentation 2013-2018
08.1.1 Market Size and Forecast
08.2 Intranasal Drug Delivery Market in the Americas
08.2.1 Market Size and Forecast
08.3 Intranasal Drug Delivery Market in the EMEA Region
08.3.1 Market Size and Forecast
08.4 Intranasal Drug Delivery Market in the APAC Region
08.4.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Becton, Dickinson and Co.
17.1.1 Key Facts
17.1.2
17.1.3 Business Description
17.1.4 Business Segmentation
17.1.5 Revenue Segmentation by Business
17.1.6 Segmental Revenue Comparison - 2013 and 2012
17.1.7 Revenue Segmentation by Geography
17.1.8 Business Strategy
17.1.9 Key Developments
17.2 SWOT Analysis
17.2.1 SWOT Overview
17.2.2 Strengths
17.2.3 Weakness
17.2.4 Opportunities
17.2.5 Threats
17.3 GlaxoSmithKline plc
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Sales by Geography
17.3.6 Pipeline Products
17.3.7 Business Strategy
17.3.8 Key Information
17.3.9 SWOT Analysis
17.3.10 Strengths
17.3.11 Weaknesses
17.3.12 Opportunities
17.3.13 Threats
17.4 Johnson & Johnson
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation by Revenue 2013
17.4.4 Business Segmentation by Revenue 2012 and 2013
17.4.5 Geographical Segmentation by Revenue 2013
17.4.6 Business Strategy
17.4.7 Recent Developments
17.4.8 SWOT Analysis
17.4.9 Strengths
17.4.10 Weaknesses
17.4.11 Opportunities
17.4.12 Threats
17.5 Novartis AG
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation by Revenue 2013
17.5.4 Business Segmentation by Revenue 2012 and 2013
17.5.5 Sales by Geography
17.5.6 Business Strategy
17.5.7 Key Developments
17.6 SWOT Analysis
17.6.1 Strengths
17.6.2 Weaknesses
17.6.3 Opportunities
17.6.4 Threats
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.